Cargando…
Safety and tolerability of solvent/detergent‐treated plasma for pediatric patients requiring therapeutic plasma exchange: An open‐label, multicenter, postmarketing study
BACKGROUND: This study investigated the real‐world safety and tolerability of solvent/detergent‐treated (S/D) plasma for pediatric patients requiring therapeutic plasma exchange (TPE). STUDY DESIGN AND METHODS: LAS‐213 was a multicenter, open‐label, interventional, phase 4 study. Patients (≥2 to ≤20...
Autores principales: | Josephson, Cassandra D., Goldstein, Stuart, Askenazi, David, Cohn, Claudia S., Spinella, Philip C., Metjian, Ara, Fasano, Ross M., Music‐Aplenc, Lejla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299645/ https://www.ncbi.nlm.nih.gov/pubmed/34931321 http://dx.doi.org/10.1111/trf.16775 |
Ejemplares similares
-
Extracorporeal photopheresis for graft-versus-host disease: the role of patient, transplant, and classification criteria and hematologic values on outcome—results from a large single-center study
por: Berger, Massimo, et al.
Publicado: (2015) -
Solvent/Detergent-Treated Plasma in the Management of Pediatric Patients Who Require Replacement of Multiple Coagulation Factors: An Open-Label, Multicenter, Post-marketing Study
por: Spinella, Philip C., et al.
Publicado: (2020) -
Solvent/detergent plasma: pharmaceutical characteristics and clinical experience
por: Liumbruno, Giancarlo Maria, et al.
Publicado: (2014) -
Risk for Hepatitis E Virus Transmission by Solvent/Detergent–Treated Plasma
por: Gallian, Pierre, et al.
Publicado: (2020) -
Orthopox viruses and the safety margins of solvent‐detergent treated plasma‐derived medicinal products
por: Kindermann, Johanna, et al.
Publicado: (2022)